Register  /  Login      
Print this index
  1. Home
  2. FROM THE SCIENTIFIC ADVISORY BOARD Topic

FROM THE SCIENTIFIC ADVISORY BOARD (35)

Chimica Oggi - Chemistry Today

Cosmetics toward peptide-based cosmeceutics
Asymmetry moves East
Chiral Technology in India and China
The evolution of chemical API manufacturing in a rapidly shifting pharma market
Regulatory affairs and a ‘licence to kill’
Quo vadis fine chemical contract manufacturing – Some thoughts for 2014
A Fear of heights, Microscopic Reversibility and King Cnut 
Serendipity and Murphy’s law are two sides of the same coin
Scale-up for Dummies 
A year of great opportunities
What is next in transition metal catalysis?
The impact of Nobel Prize in Chemistry on fine chemicals
Peptide chemistry revolution
The customer bond
Some Applications of Murphy’s Law in Process Chemistry
Pharma Custom Manufacturing today
Green chemistry and pharmaceutical innovation at the crossroads
How similar is Biosimilar?
The complexity of technology implementation: flow versus batch processing
As time flows by

Agro FOOD Industry Hi Tech

Defining nutrients
Are some antioxidants left on the sidelines?
Food Labelling: Underutilised opportunities to improve public health
Polyphenols as Xenohormetics
The future approach to prevent human chronic diseases
Are we ready to accept modern crop biotechnology?
To treat or not to treat normal-to-high blood pressure?
Food choice: reason, drive or learned behaviour?
Essential fatty acidsand their metabolites
as modulators of stem cell biology
Crisis, science dissemination and R&D investment: solving the equation of the European technological future
Functional ingredients; quo vadis?
Seeing is (not necessarily) believing?
Advanced technologiesfor food and beverage quality control
The importanceof the normal microbiota How to claim it?
Infant nutrition and its impact on adult diseases
100 years of vitamins

H&PCToday
Household and Personal Care Today

Analytical separation technology
A 25 year evolution
Evidence based cosmetics vs. cosmeceuticals

Pharma Horizon

There are no posts with FROM THE SCIENTIFIC ADVISORY BOARD topic in this journal... yet.